In the latest episode of The Moonlight Shift, @Jonathanwlee23 and @Jani_Chinmay join to share their experiences as fellows and the journey to the next phases of their careers #oncology
Watch here👀: https://t.co/1OIK8Poi8H
🗣️ While taking over OncLive's X account at #ASCO26, @Jonathanwlee23 caught up with @DoughertySC91 to discuss his team's research on tarlatamab in SCLC.
From real-world CRS and ICANS management to building an outpatient treatment model, Dougherty shares how his team is helping bring bispecific therapy into everyday practice. 🔬
🎥 Watch now! @ASCO #lcsm #SCLC
What advice would a seasoned ASCO attendee give someone attending the meeting for the first time?
During his OncLive X Takeover, @Jonathanwlee23 caught up with @mdmanishshah of @WeillCornell, who shared practical tips for navigating ASCO, balancing sessions, and making the most of the meeting as a first-time attendee.
Watch below! ⬇️
#ASCO26 #oncology #meded
What a fun conversation on The Moonlight Shift! 🎙️
Had an amazing time chatting with @Jonathanwlee23 about our fellowship journey, the lessons we've learned along the way, mentors who shaped our career and the exciting transition to our next chapter as attending physicians.
Jonathan at @StanfordMed as GU oncologist and me at @SylvesterCancer - as thoracic oncologists and Phase-1 clinical trialist.
A huge thank you to @ginacolumbusonc and the entire @MJHLifeSciences team for the warm hospitality and for creating such a fantastic platform to share our stories. Looking forward to many more conversations like this!
@GlopesMd@Latinamd@SylvesterCancer@HemOncMiami@DocOncMD@FLASCO_ORG
Give it a watch! 🎙️🫁 👇
https://t.co/lrxvcfEa4Z
🤝 One of the best lessons I've learned is the importance of finding your tribe.
Grateful to now call many of these friends and colleagues my tribe in oncology, thoracic oncology, and medical education after knowing many of them for almost 2-3 years.
🙏 Special thanks to @Jonathanwlee23 for being an incredible partner in medical education initiatives along the way.
🫁📚🧬 #ASCO26 #MedEd #Oncology
@OncLive@ASCO@ASCOTECAG@SylvesterCancer
An @ASCO for the books! From absolutely incredible science, to new collaborations, and celebrating huge and hard earned achievements! Here’s to revolutionary breakthroughs in cancer care!
Daraxonrasib is the PDAC IT GIRL! Rowdy crowd at the #ASCO26 plenary session. Applauses heard around the world. An emotional day for many. Congratulations to @RevMedicines and the investigators including @DrShubhamPant@DavidHongMD. And THANK YOU to our patients ❤️ #RASolute302
Still thinking about the landmark CROWN 7-year lorlatinib update.
Beyond the stats, this represents real, meaningful time for our patients & families living life while managing scans, visits, & AEs. CROWN is setting a phenomenal new benchmark for all TKIs to strive for! #ASCO26
Are oncology conferences meeting the needs of a growing cancer survivor population? 📊
We analyzed @ASCO Annual Meeting abstracts (2022-2024) reveals that while #survivorship content saw a modest increase (2.2% to 4.1%), it remains largely static overall. #ASCO26
A study looked to determine how much emphasis there has been on topics related to #cancer survivors by quantifying the coverage at previous @ASCO Annual Meetings. @christinemphmd shares more from #ASCO26: https://t.co/SitfaHatvW